UNSPSC 51285203: Trimethoprim

This classification denotes a urinary anti-infective agent with the molecular formula C14H18N4O3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier AN164J8Y0X, chemically known as 2,4-pyrimidinediamine, 5-((3,4,5-trimethoxyphenyl)methyl)- but more generally known as trimethoprim, which bears U.S. National Institutes of Health Compound Identifier 5578. The European Medicines Agency schedules Trimethoprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11310MIG.

UNSPSC 51285203 Trimethoprim is a Commodity code that in recent state and local procurement activity captures pharmaceutical procurement more broadly than the narrow code name suggests—specifically, emergency medical supplies, naloxone and drug deactivation systems, generic pharmaceuticals, and over-the-counter products sourced through state and local health agencies, fire departments, and multistate cooperative purchasing programs. State and local governments buying under this code include city fire departments (Tampa), county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota, Oregon, and participating jurisdictions). The work ranges from tactical procurement of discrete medical consumables—respiratory equipment, cardiac monitoring electrodes, endotracheal tubes, bandaging materials, and oxygen delivery systems for emergency response—to strategic contracting with pharmaceutical manufacturers and wholesalers for generic drug distribution across multiple government facilities and health plans.

Recent activity spans Florida, Texas, and the upper Midwest (Minnesota and Oregon). The City of Tampa issued an IFB (26P00145) for medical and first aid supplies totaling an estimated $700,000 with a March 13, 2026 response deadline and an SLBE set-aside with a 5% bid discount capped at $10,000. Seminole County, Florida solicited an IFB (IFB60459723LAS) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a July 26, 2023 deadline. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802) for generic multi-source pharmaceuticals and OTC products due March 26, 2026, requiring vendors to supply through three authorized wholesalers and pay a 3% administrative fee. The Texas Health and Human Services Commission released a Request for Information (HHS0017013) on April 3, 2026 to gather market intelligence on direct-to-manufacturer prescription programs, signaling early-stage procurement planning for future formal solicitations.